Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurological disorders
Biotech
Astellas pays Sangamo $20M to boost neurological gene therapies
Astellas continues to strengthen its neurological gene therapy capabilities, handing Sangamo $20 million upfront to bypass the blood-brain barrier.
James Waldron
Dec 19, 2024 7:13am
Acadia inks $582M biobucks pact for Danish biotech's neuro asset
Nov 26, 2024 5:00pm
Kronos shelves sole clinical drug over neurological side effects
Nov 14, 2024 5:14am
Roche bets up to $1B to expand Dyno gene therapy delivery pact
Oct 24, 2024 10:40am
Addex stock rises after Indivior offers up to $300M for compound
Aug 27, 2024 10:50am
NeuroOne nabs nod for brain monitoring and ablation system
Dec 11, 2023 11:42am
